Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$53.82

-3.83 (-6.64%)

, ANTM

Anthem

$120.84

-1.06 (-0.87%)

13:13
10/12/16
10/12
13:13
10/12/16
13:13

Anthem says policy unchanged on Sarepta's Exondys 51, Bloomberg reports

Bloomberg cites an emailed comment from an Anthem spokesperson.

SRPT

Sarepta

$53.82

-3.83 (-6.64%)

ANTM

Anthem

$120.84

-1.06 (-0.87%)

  • 02

    Nov

  • 06

    Nov

SRPT Sarepta
$53.82

-3.83 (-6.64%)

10/07/16
BARD
10/07/16
NO CHANGE
Target $102
BARD
Outperform
Anthem policy does not mean insurer not covering Sarepta drug, says Baird
Baird analyst Brian Skorney noted Anthem (ANTM) has categorized Sarepta (SRPT) Duchenne muscular dystrophy drug Exondys 51 as "not medically necessary" in a new coverage policy, but he cautions this "does not mean that Anthem is not covering the drug." The analyst explains that the policy means prior authorization requirements may be stricter, but he "highly doubts" that eligible patients will be denied coverage. Skorney, who adds that other large insurers appear to have favorable coverage for the drug, keeps an Outperform rating and $102 price target on Sarepta shares.
10/05/16
ADAM
10/05/16
NO CHANGE
Target $28
ADAM
Buy
Summit Therapeutics price target raised to $28 from $14 at Canaccord
Canaccord analyst Arinda Lee raised her price target on Summit Therapeutics (SMMT) to $28 from $14 following the announcement of its collaboration and licensing agreement with Sarepta Therapeutics (SRPT). The deal calls for Sarepta to gain EU commercialization rights to Summit's pipeline of oral utrophin modulators for all patients with Duchenne muscular dystrophy. Lee reiterated her Buy rating Summit Therapeutics shares.
10/04/16
PIPR
10/04/16
NO CHANGE
Target $68
PIPR
Overweight
Piper Jaffray ups Sarepta target to $68 on Summit deal
Piper Jaffray analyst Edward Tenthoff raised his price target for Sarepta Therapeutics (SRPT) to $68 from $64 after the company licensed Summit Therapeutics' (SMMT) ezutromid to treat Duchenne Muscular Dystrophy in Europe, Turkey and the Commonwealth of Independent States. The deal is a smart way for Sarepta to capitalize on its lead in DMD with the recent FDA approval of Exondys51, Tenthoff tells investors in an intraday research note. His new price target of $68 reflects the value of ezutromid. Tenthoff reiterates an Overweight rating on Sarepta. The stock is up 1% to $61.61 in late morning trading. Summit is up 94%, or $8.17, to $16.82.
09/28/16
JMPS
09/28/16
NO CHANGE
JMPS
Street underestimating price of Sarepta drug, says JMP Securities
JMP Securities analyst Liisa Bayko expects the price of Sarepta's Exondys 51 drug will be above the company's projected annual net price of $300,000. She thinks that the price will come in "closer to $538,000 per year on a gross basis, $457,000 net of discounts and compliance." The analyst raised her price target on the shares to $90 from $60 and keeps an Outperform rating on the stock.
ANTM Anthem
$120.84

-1.06 (-0.87%)

09/22/16
EVER
09/22/16
INITIATION
Target $133
EVER
Hold
Anthem initiated with a Hold at Evercore ISI
Evercore ISI initiated Anthem with a Hold and a $133 price target.
09/20/16
BOFA
09/20/16
NO CHANGE
BOFA
Anthem removed from US 1 List at BofA/Merrill
09/13/16
JEFF
09/13/16
DOWNGRADE
Target $138
JEFF
Hold
Anthem downgraded to Hold from Buy at Jefferies
Jefferies analyst David Windley downgraded Anthem (ANTM) to Hold from Buy saying the restoration of some of the company's expense cuts could limit 2017 earnings growth. "The belt-tightening also potentially signals under-investment in the platform," Windley tells investors in a research note. He sees a lack of catalysts for Anthem shares and cut his price target to $138 from $156. The health benefit company closed yesterday up $1.63 to $128.58. In Managed Care, Windley's top pick is UnitedHealth (UNH). The company has an attractive valuation and "best-in-class" management team, Windley argues. He has a Buy rating on UnitedHealth with a $163 price target.
08/25/16
COWN
08/25/16
NO CHANGE
COWN
Managed Care mergers unlikely to close, says Cowen
Cowen analyst Christine Arnold believes the current managed care mergers including Aetna (AET) and Humana (HUM) and Anthem (ANTM) and Cigna (CI) are unlikely to close. The analyst said the government's ability to appeal could extend the litigation process beyond the termination dates stipulated in the merger agreements. Arnold believes the Aetna/Humana merger has a better chance of closing relative to the Anthem/Cigna deal, but believes neither are likely to close.

TODAY'S FREE FLY STORIES

RICK

RCI Hospitality

$17.16

0.29 (1.72%)

17:29
04/26/17
04/26
17:29
04/26/17
17:29
Hot Stocks
RCI Hospitality acquires assets of St. Louis real estate and gentlemen's club »

RCI Hospitality acquired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

MTGE

MTGE Investment Corp.

$17.85

0.15 (0.85%)

, AGNC

AGNC Investment

$20.80

-0.07 (-0.34%)

17:27
04/26/17
04/26
17:27
04/26/17
17:27
Hot Stocks
AGNC Investment may invest in MTGE Investment Corp. common stock »

AGNC Investment's…

MTGE

MTGE Investment Corp.

$17.85

0.15 (0.85%)

AGNC

AGNC Investment

$20.80

-0.07 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

  • 04

    May

LVS

Las Vegas Sands

$59.26

0.79 (1.35%)

17:26
04/26/17
04/26
17:26
04/26/17
17:26
Hot Stocks
Las Vegas Sands reports Q1 Venetian Macao net revenue down 1.1% to $741M »

Reports Q1 Venetian Macao…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 31

    May

DEI

Douglas Emmett

$38.25

-0.56 (-1.44%)

17:22
04/26/17
04/26
17:22
04/26/17
17:22
Hot Stocks
Douglas Emmett acquires two Santa Monica office buildings for $352.8M »

Douglas Emmett has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 01

    Jun

PEGI

Pattern Energy

$22.24

0.08 (0.36%)

17:21
04/26/17
04/26
17:21
04/26/17
17:21
Hot Stocks
Pattern Energy acquires 324 megawatt Broadview Wind in NM »

Pattern Energy Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 01

    Jun

CSLT

Castlight Health

$4.15

0.05 (1.22%)

17:20
04/26/17
04/26
17:20
04/26/17
17:20
Earnings
Castlight Health sees 2017 non-GAAP EPS (28c)-(24c), consensus (14c) »

Sees 2017 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 06

    Jun

KRA

Kraton Performance

$33.14

-0.26 (-0.78%)

17:20
04/26/17
04/26
17:20
04/26/17
17:20
Hot Stocks
Kraton Performance sees FY17 adjusted EBITDA about $350M »

Expects to reduce net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

KRA

Kraton Performance

$33.14

-0.26 (-0.78%)

17:19
04/26/17
04/26
17:19
04/26/17
17:19
Earnings
Kraton Performance reports Q1 adjusted EPS (15c), consensus (20c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

GG

Goldcorp

$14.53

0.17 (1.18%)

17:18
04/26/17
04/26
17:18
04/26/17
17:18
Earnings
Goldcorp reports Q1 EPS 20c, consensus 8c »

Reports Q1 gold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

CSLT

Castlight Health

$4.15

0.05 (1.22%)

17:18
04/26/17
04/26
17:18
04/26/17
17:18
Earnings
Castlight Health reports Q1 non-GAAP EPS (5c), consensus (5c) »

Reports Q1 revenue $27.7,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 06

    Jun

HUBG

Hub Group

$40.15

-0.25 (-0.62%)

17:18
04/26/17
04/26
17:18
04/26/17
17:18
Hot Stocks
Hub Group sees FY17 CapEx $90M-$100M »

Says truck brokerage and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 10

    May

CNI

Canadian National

$72.39

-0.71 (-0.97%)

17:17
04/26/17
04/26
17:17
04/26/17
17:17
Hot Stocks
Canadian National to purchase shares under a specific share repurchase program »

CN announced that it will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PKG

Packaging Corp.

$94.54

0.18 (0.19%)

17:17
04/26/17
04/26
17:17
04/26/17
17:17
Earnings
Packaging Corp.reports Q1 EPS $1.27, consensus $1.23 »

Reports Q1 revenue $1.5B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

MAA

MAA

$101.00

-0.47 (-0.46%)

17:16
04/26/17
04/26
17:16
04/26/17
17:16
Earnings
MAA sees 2017 EPS $2.54-$2.74, consensus $2.29 »

Sees 2017 FFO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

MKL

Markel

$978.01

-2.31 (-0.24%)

17:15
04/26/17
04/26
17:15
04/26/17
17:15
Earnings
Markel reports Q1 diluted EPS $3.90, may not compare to consensus $4.80 »

Markel reported book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

SSW

Seaspan

$6.56

0.29 (4.63%)

17:15
04/26/17
04/26
17:15
04/26/17
17:15
Earnings
Seaspan reports Q1 normalized EPS 15c, consensus 13c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

MAA

MAA

$101.00

-0.47 (-0.46%)

17:14
04/26/17
04/26
17:14
04/26/17
17:14
Earnings
MAA reports Q1 EPS 36c with items, consensus 54c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

INDB

Independent Bank

$66.50

0.7 (1.06%)

17:12
04/26/17
04/26
17:12
04/26/17
17:12
Hot Stocks
Independent Bank says receives all regulatory approvals for Island merger »

Independent Bank and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

  • 18

    May

CRY

CryoLife

$16.75

0.5 (3.08%)

17:11
04/26/17
04/26
17:11
04/26/17
17:11
Earnings
CryoLife sees FY17 adjusted EPS 40c-43c, consensus 41c »

Sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 03

    May

CRY

CryoLife

$16.75

0.5 (3.08%)

17:10
04/26/17
04/26
17:10
04/26/17
17:10
Earnings
CryoLife reports Q1 adjusted EPS 9c, consensus 4c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 03

    May

CSV

Carriage Services

$28.82

0.24 (0.84%)

17:09
04/26/17
04/26
17:09
04/26/17
17:09
Earnings
Carriage Services reports Q1 adjusted EPS 45c, consensus 49c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 08

    May

  • 09

    May

  • 10

    May

  • 17

    May

SIGI

Selective Insurance

$48.90

0.6 (1.24%)

17:08
04/26/17
04/26
17:08
04/26/17
17:08
Hot Stocks
Selective Insurance sees FY17 catastrophe losses of 3.5 points »

Sees FY17 statutory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

OII

Oceaneering

$26.32

-0.1 (-0.38%)

17:08
04/26/17
04/26
17:08
04/26/17
17:08
Hot Stocks
Oceaneering sees 'income improvements from all of our business segments' in Q2 »

Management said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

SIGI

Selective Insurance

$48.90

0.6 (1.24%)

17:07
04/26/17
04/26
17:07
04/26/17
17:07
Earnings
Selective Insurance reports Q1 operating EPS 86c, consensus 75c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

OII

Oceaneering

$26.32

-0.1 (-0.38%)

17:07
04/26/17
04/26
17:07
04/26/17
17:07
Earnings
Oceaneering reports Q1 adjusted EPS (4c), consensus (10c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.